Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 08, 2015 3:09 PM ET


Company Overview of Opexa Therapeutics, Inc.

Executive Profile

Gail J. Maderis

Independent Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee, Opexa Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Ms. Gail J. Maderis serves as the Chief Executive Officer and President of Bay Area Bioscience Association (formerly, BayBio). Ms. Maderis served as the Chief Executive Officer and President of Five Prime Therapeutics, Inc. until June 18, 2009. Prior to joining FivePrime in July 2003, she spent eleven years at Genzyme Corporation in various business development and general management positions. While at Genzyme, she founded and served as President of Genzyme Molecular ...

Corporate Headquarters

2635 Technology Forest Boulevard
The Woodlands, Texas 77381

United States

Phone: 281-272-9331
Fax: 281-872-8585

Board Members Memberships

Director, Member of Audit Committee and Member of Compensation Committee
Independent Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee


Harvard Business School
University of California Berkeley

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$15,000
Total Calculated Compensation$55,000

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Caladrius Biosciences, Inc.
Linda F. Powers J.D.Chairperson, Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer
Northwest Biotherapeutics, Inc.
Zhilin Li Chairman, Chief Executive Officer, President and Interim Chief Financial Officer
China Pharma Holdings, Inc.
Guoqing Jiang M.D.Chairman, Chief Executive Officer, President, Acting Chief Financial Officer and Chief Accounting Officer
Tianyin Pharmaceutical Co., Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Opexa Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at